着床前遺伝子診断（PGD）の世界市場規模、シェア、業界動向分析：検査タイプ別、地域別の展望と予測（2022年～2028年）

世界の着床前遺伝子診断（PGD）の市場規模は、2028年までに1億5,980万米ドルに達し、予測期間中にCAGR9.7%で成長すると予測されています。

市場は、遺伝性疾患を持つ人々が着床前遺伝子検査の利点を認識するようになったことにより急速に成長しています。さらに、不妊症の割合や先天性異常の数の増加が、予測期間中の市場成長を後押しすると予想されます。一方で、公的機関による倫理的受容性と司法統制が着床前遺伝子診断（PGD）サービスの導入率を妨げています。

当レポートでは、世界の着床前遺伝子診断（PGD）市場について調査し、市場に影響を与える主な要因、競合分析、セグメント・地域別の市場分析、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場の範囲と調査手法

第2章 市場概要

• イントロダクション
• 市場に影響を与える主な要因

第3章 世界の着床前遺伝子診断（PGD）市場：検査タイプ別

• 異数性
• 染色体異常
• X連鎖性疾患
• 単一遺伝子障害
• HLAタイピング
• 性別選択
• その他

第4章 世界の着床前遺伝子診断（PGD）市場：地域別

• 北米の着床前遺伝子診断（PGD）市場
• 欧州の着床前遺伝子診断（PGD）市場
• アジア太平洋の着床前遺伝子診断（PGD）市場
• ラテンアメリカ・中東・アフリカの着床前遺伝子診断（PGD）市場

第5章 企業プロファイル

• Illumina, Inc.
• Invitae Corporation
• Natera Inc.
• Agilent Technologies, Inc.
• PerkinElmer, Inc.
• Quest Diagnostics Incorporated
• Reproductive Genetic Innovations
• PacGenomics
• CeGaT GmbH
• Laboratory Corporation of America Holdings

LIST OF TABLES

• TABLE 1 Global Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 2 Global Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 3 Global Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 4 Global Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 5 Global Aneuploidy Market by Region, 2018 - 2021, USD Thousands
• TABLE 6 Global Aneuploidy Market by Region, 2022 - 2028, USD Thousands
• TABLE 7 Global Chromosomal Abnormalities Market by Region, 2018 - 2021, USD Thousands
• TABLE 8 Global Chromosomal Abnormalities Market by Region, 2022 - 2028, USD Thousands
• TABLE 9 Global X-linked diseases Market by Region, 2018 - 2021, USD Thousands
• TABLE 10 Global X-linked diseases Market by Region, 2022 - 2028, USD Thousands
• TABLE 11 Global Single Gene Disorders Market by Region, 2018 - 2021, USD Thousands
• TABLE 12 Global Single Gene Disorders Market by Region, 2022 - 2028, USD Thousands
• TABLE 13 Global HLA Typing Market by Region, 2018 - 2021, USD Thousands
• TABLE 14 Global HLA Typing Market by Region, 2022 - 2028, USD Thousands
• TABLE 15 Global Gender selection Market by Region, 2018 - 2021, USD Thousands
• TABLE 16 Global Gender selection Market by Region, 2022 - 2028, USD Thousands
• TABLE 17 Global Other Test Type Market by Region, 2018 - 2021, USD Thousands
• TABLE 18 Global Other Test Type Market by Region, 2022 - 2028, USD Thousands
• TABLE 19 Global Preimplantation Genetics Diagnosis (PGD) Market by Region, 2018 - 2021, USD Thousands
• TABLE 20 Global Preimplantation Genetics Diagnosis (PGD) Market by Region, 2022 - 2028, USD Thousands
• TABLE 21 North America Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 22 North America Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 23 North America Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 24 North America Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 25 North America Aneuploidy Market by Country, 2018 - 2021, USD Thousands
• TABLE 26 North America Aneuploidy Market by Country, 2022 - 2028, USD Thousands
• TABLE 27 North America Chromosomal Abnormalities Market by Country, 2018 - 2021, USD Thousands
• TABLE 28 North America Chromosomal Abnormalities Market by Country, 2022 - 2028, USD Thousands
• TABLE 29 North America X-linked diseases Market by Country, 2018 - 2021, USD Thousands
• TABLE 30 North America X-linked diseases Market by Country, 2022 - 2028, USD Thousands
• TABLE 31 North America Single Gene Disorders Market by Country, 2018 - 2021, USD Thousands
• TABLE 32 North America Single Gene Disorders Market by Country, 2022 - 2028, USD Thousands
• TABLE 33 North America HLA Typing Market by Country, 2018 - 2021, USD Thousands
• TABLE 34 North America HLA Typing Market by Country, 2022 - 2028, USD Thousands
• TABLE 35 North America Gender selection Market by Country, 2018 - 2021, USD Thousands
• TABLE 36 North America Gender selection Market by Country, 2022 - 2028, USD Thousands
• TABLE 37 North America Other Test Type Market by Country, 2018 - 2021, USD Thousands
• TABLE 38 North America Other Test Type Market by Country, 2022 - 2028, USD Thousands
• TABLE 39 North America Preimplantation Genetics Diagnosis (PGD) Market by Country, 2018 - 2021, USD Thousands
• TABLE 40 North America Preimplantation Genetics Diagnosis (PGD) Market by Country, 2022 - 2028, USD Thousands
• TABLE 41 US Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 42 US Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 43 US Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 44 US Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 45 Canada Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 46 Canada Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 47 Canada Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 48 Canada Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 49 Mexico Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 50 Mexico Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 51 Mexico Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 52 Mexico Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 53 Rest of North America Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 54 Rest of North America Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 55 Rest of North America Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 56 Rest of North America Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 57 Europe Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 58 Europe Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 59 Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 60 Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 61 Europe Aneuploidy Market by Country, 2018 - 2021, USD Thousands
• TABLE 62 Europe Aneuploidy Market by Country, 2022 - 2028, USD Thousands
• TABLE 63 Europe Chromosomal Abnormalities Market by Country, 2018 - 2021, USD Thousands
• TABLE 64 Europe Chromosomal Abnormalities Market by Country, 2022 - 2028, USD Thousands
• TABLE 65 Europe X-linked diseases Market by Country, 2018 - 2021, USD Thousands
• TABLE 66 Europe X-linked diseases Market by Country, 2022 - 2028, USD Thousands
• TABLE 67 Europe Single Gene Disorders Market by Country, 2018 - 2021, USD Thousands
• TABLE 68 Europe Single Gene Disorders Market by Country, 2022 - 2028, USD Thousands
• TABLE 69 Europe HLA Typing Market by Country, 2018 - 2021, USD Thousands
• TABLE 70 Europe HLA Typing Market by Country, 2022 - 2028, USD Thousands
• TABLE 71 Europe Gender selection Market by Country, 2018 - 2021, USD Thousands
• TABLE 72 Europe Gender selection Market by Country, 2022 - 2028, USD Thousands
• TABLE 73 Europe Other Test Type Market by Country, 2018 - 2021, USD Thousands
• TABLE 74 Europe Other Test Type Market by Country, 2022 - 2028, USD Thousands
• TABLE 75 Europe Preimplantation Genetics Diagnosis (PGD) Market by Country, 2018 - 2021, USD Thousands
• TABLE 76 Europe Preimplantation Genetics Diagnosis (PGD) Market by Country, 2022 - 2028, USD Thousands
• TABLE 77 Germany Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 78 Germany Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 79 Germany Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 80 Germany Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 81 UK Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 82 UK Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 83 UK Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 84 UK Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 85 France Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 86 France Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 87 France Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 88 France Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 89 Russia Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 90 Russia Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 91 Russia Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 92 Russia Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 93 Spain Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 94 Spain Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 95 Spain Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 96 Spain Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 97 Italy Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 98 Italy Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 99 Italy Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 100 Italy Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 101 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 102 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 103 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 104 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 105 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 106 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 107 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 108 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 109 Asia Pacific Aneuploidy Market by Country, 2018 - 2021, USD Thousands
• TABLE 110 Asia Pacific Aneuploidy Market by Country, 2022 - 2028, USD Thousands
• TABLE 111 Asia Pacific Chromosomal Abnormalities Market by Country, 2018 - 2021, USD Thousands
• TABLE 112 Asia Pacific Chromosomal Abnormalities Market by Country, 2022 - 2028, USD Thousands
• TABLE 113 Asia Pacific X-linked diseases Market by Country, 2018 - 2021, USD Thousands
• TABLE 114 Asia Pacific X-linked diseases Market by Country, 2022 - 2028, USD Thousands
• TABLE 115 Asia Pacific Single Gene Disorders Market by Country, 2018 - 2021, USD Thousands
• TABLE 116 Asia Pacific Single Gene Disorders Market by Country, 2022 - 2028, USD Thousands
• TABLE 117 Asia Pacific HLA Typing Market by Country, 2018 - 2021, USD Thousands
• TABLE 118 Asia Pacific HLA Typing Market by Country, 2022 - 2028, USD Thousands
• TABLE 119 Asia Pacific Gender selection Market by Country, 2018 - 2021, USD Thousands
• TABLE 120 Asia Pacific Gender selection Market by Country, 2022 - 2028, USD Thousands
• TABLE 121 Asia Pacific Other Test Type Market by Country, 2018 - 2021, USD Thousands
• TABLE 122 Asia Pacific Other Test Type Market by Country, 2022 - 2028, USD Thousands
• TABLE 123 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Country, 2018 - 2021, USD Thousands
• TABLE 124 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Country, 2022 - 2028, USD Thousands
• TABLE 125 China Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 126 China Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 127 China Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 128 China Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 129 Japan Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 130 Japan Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 131 Japan Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 132 Japan Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 133 India Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 134 India Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 135 India Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 136 India Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 137 South Korea Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 138 South Korea Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 139 South Korea Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 140 South Korea Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 141 Singapore Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 142 Singapore Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 143 Singapore Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 144 Singapore Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 145 Malaysia Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 146 Malaysia Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 147 Malaysia Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 148 Malaysia Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 149 Rest of Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 150 Rest of Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 151 Rest of Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 152 Rest of Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 153 LAMEA Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 154 LAMEA Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 155 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 156 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 157 LAMEA Aneuploidy Market by Country, 2018 - 2021, USD Thousands
• TABLE 158 LAMEA Aneuploidy Market by Country, 2022 - 2028, USD Thousands
• TABLE 159 LAMEA Chromosomal Abnormalities Market by Country, 2018 - 2021, USD Thousands
• TABLE 160 LAMEA Chromosomal Abnormalities Market by Country, 2022 - 2028, USD Thousands
• TABLE 161 LAMEA X-linked diseases Market by Country, 2018 - 2021, USD Thousands
• TABLE 162 LAMEA X-linked diseases Market by Country, 2022 - 2028, USD Thousands
• TABLE 163 LAMEA Single Gene Disorders Market by Country, 2018 - 2021, USD Thousands
• TABLE 164 LAMEA Single Gene Disorders Market by Country, 2022 - 2028, USD Thousands
• TABLE 165 LAMEA HLA Typing Market by Country, 2018 - 2021, USD Thousands
• TABLE 166 LAMEA HLA Typing Market by Country, 2022 - 2028, USD Thousands
• TABLE 167 LAMEA Gender selection Market by Country, 2018 - 2021, USD Thousands
• TABLE 168 LAMEA Gender selection Market by Country, 2022 - 2028, USD Thousands
• TABLE 169 LAMEA Other Test Type Market by Country, 2018 - 2021, USD Thousands
• TABLE 170 LAMEA Other Test Type Market by Country, 2022 - 2028, USD Thousands
• TABLE 171 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Country, 2018 - 2021, USD Thousands
• TABLE 172 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Country, 2022 - 2028, USD Thousands
• TABLE 173 Brazil Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 174 Brazil Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 175 Brazil Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 176 Brazil Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 177 Argentina Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 178 Argentina Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 179 Argentina Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 180 Argentina Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 181 UAE Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 182 UAE Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 183 UAE Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 184 UAE Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 185 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 186 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 187 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 188 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 189 South Africa Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 190 South Africa Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 191 South Africa Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 192 South Africa Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 193 Nigeria Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 194 Nigeria Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 195 Nigeria Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 196 Nigeria Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 197 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
• TABLE 198 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
• TABLE 199 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
• TABLE 200 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
• TABLE 201 key information - Illumina, Inc.
• TABLE 202 Key Information - Invitae Corporation
• TABLE 203 Key Information - Natera Inc.
• TABLE 204 key Information - Agilent Technologies, Inc.
• TABLE 205 key Information - PerkinElmer, Inc.
• TABLE 206 Key information - Quest Diagnostics Incorporated
• TABLE 207 Key information - Reproductive Genetic Innovations
• TABLE 208 Key Information - PacGenomics
• TABLE 209 key information - CeGaT GmbH
• TABLE 210 Key Information - Laboratory Corporation of America holdings

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Test Type, 2021
• FIG 3 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Test Type, 2028
• FIG 4 Global Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2028, USD Thousands
• FIG 5 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Region, 2021
• FIG 6 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Region, 2028
• FIG 7 Global Preimplantation Genetics Diagnosis (PGD) Market by Region, 2018 - 2028, USD Thousands

The Global Preimplantation Genetics Diagnosis (PGD) Market size is expected to reach $159.8 million by 2028, rising at a market growth of 9.7% CAGR during the forecast period.

Preimplantation genetic testing (PGD) is a procedure for discovering genetic problems in in-vitro fertilization (IVF) embryos before pregnancy. In addition, PGD is doing tests on embryos to identify whether they are genetically defective. PGD is a non-invasive treatment that can be used instead of conventional post-conception diagnostic procedures. PGD is a technology used in IVF genetic testing that allows for a more thorough analysis of embryos than just their appearance. By completing embryo genetic testing, PGD considerably reduces the possibility of generating harmful embryos, which is a major driving force for the market's growth.

Preimplantation genetic testing is the process of genetically profiling embryos and, in certain cases, oocytes before fertilization to ensure a successful pregnancy. By detecting the presence of illness during the course of gestation, these tests assist couples who are at risk of inherited abnormalities in making the best decision about whether or not to terminate the pregnancy. These tests are also beneficial to women in IVF cycles who have had previous miscarriages or who had a previous pregnancy with genetic abnormalities.

Preimplantation genetic diagnosis (PGD), often known as embryo screening, is a branch of genetics that entails genetic testing of an embryo created by in vitro fertilization (IVF). PGD eliminates the possibility of selective pregnancy termination for couples who are at high risk of passing on major genetic, chromosomal, or inherited illnesses such as spinal muscular atrophy or cystic fibrosis.

The global Preimplantation Genetic Testing Market has grown rapidly as people with genetic disorders become more aware of the benefits of preimplantation genetic testing. Furthermore, during the forecast period, the rising rate of infertility is expected to propel the worldwide Preimplantation Genetic Testing Market forward.

COVID-19 Impact

The novel coronavirus has rapidly spread throughout multiple countries and regions, wreaking havoc on people's lives and the community as a whole. It started as a human health issue and has since evolved into a major threat to global trade, economics, and finance. The COVID-19 pandemic raised the relevance of government healthcare facilities, resulting in an increase in global healthcare spending. Moreover, once the COVID-19 vaccine is brought into the market, COVID-19 instances are likely to decrease in the future. As a result, businesses that provide PGD have reopened. By the beginning of 2022, the market had recovered. To respond to urgent emergencies and build new working techniques post-pandemic, companies focus on protecting their employees, operations, and supply networks. Furthermore, the financial downturn caused by COVID-19 had a detrimental impact on the expansion of the preimplantation genetics diagnosis sector.

Market Growth Factors

Advanced Healthcare services and Increased awareness

The growing demand for better healthcare services and rising disposable money are creating opportunities for sophisticated diagnostic and treatment approaches to be developed. Because of the growing need to prevent physical deformities and health issues in newborns, early diagnostic approaches have gained significance in the healthcare sector during genetic IVF techniques and other artificial insemination operations. By evaluating genetic differences at the embryonic stage, preimplantation diagnostic testing can determine hereditary illnesses like cystic fibrosis, congenital hearing loss, and thalassemia. Furthermore, governments and non-profit organizations are working to raise awareness about the benefits of early genetic disease detection in order to improve the health of women and children.

A rise in the number of birth defects

Increased demand for preimplantation diagnostic and screening techniques is attributable to an increase in the occurrence of a single gene, mitochondrial, and other gene-related illnesses. According to the Florida Department of Health, nearly one out of every 28 babies in the state is diagnosed with a birth defect each year. For a successful pregnancy, preimplantation genetic diagnosis (PGD) is used prior to IVF. PGD can be used in IVF cycles for women who have had many miscarriages or who have had a previous pregnancy with a chromosomal issue. PGD has the potential to aid couples at risk of inherited illnesses.

Market Restraining Factors

Ethical implications and the possibility of undetected diseases

Despite the various benefits of preimplantation genetic testing, there are some barriers to the growth of the industry. One of the major barriers is ethical acceptability and judicial controls by public bodies, which prevent the adoption rate of PGT services. Additionally, a few clinicians and researchers have questioned the efficacy of these techniques. Additionally, few people consider preimplantation genetic diagnosis to be morally objectionable because it involves the intentional development and killing of an abnormal human embryo. However, some organizations are advocating that people must be free of guilt when it comes to passing on the challenges of genetic illnesses to their offspring.

Test Type Outlook

Based on Test Type, the market is segmented into Aneuploidy, Chromosomal Abnormalities, X-linked diseases, Single Gene Disorders, HLA Typing, Gender selection, and Others. In 2021, the Aneuploidy segment garnered the maximum revenue share of the Preimplantation Genetics Diagnosis (PGD) Market. Preimplantation genetic testing for aneuploidy has been proposed as a technique to detect whole chromosomal aneuploidy prior to transfer, potentially increasing live birth rates and lowering early pregnancy failure rates. Preimplantation genetic testing for aneuploidy has been expanded to encompass evaluation of all chromosomes using techniques like array comparative genomic hybridization and next-generation sequencing.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2021, the North America emerged as the dominating region in the Preimplantation Genetics Diagnosis (PGD) Market by accounting for the largest revenue share. This is due to an increase in the number of people living in the country and an increase in the amount of money spent on healthcare. According to the United States Department of Health and Human Services, there are 489 fertility clinics in the United States that provide ART solutions as of 2019. States including Massachusetts, Columbia, and New Jersey has the greatest proportion of ART births. Furthermore, a growth in awareness of healthy embryos in poorer nations is likely to provide a business potential for preimplantation genetic diagnosis.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Illumina, Inc., Invitae Corporation, Natera, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Reproductive Genetic Innovations, PacGenomics, CeGaT GmbH, and Laboratory Corporation of America Holdings.

Scope of the Study

Market Segments covered in the Report:

By Test Type

• Aneuploidy
• Chromosomal Abnormalities
• X-linked diseases
• Single Gene Disorders
• HLA Typing
• Gender selection
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Illumina, Inc.
• Invitae Corporation
• Natera, Inc.
• Agilent Technologies, Inc.
• PerkinElmer, Inc.
• Quest Diagnostics Incorporated
• Reproductive Genetic Innovations
• PacGenomics
• CeGaT GmbH
• Laboratory Corporation of America Holdings

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Preimplantation Genetics Diagnosis (PGD) Market, by Test Type
  • 1.4.2 Global Preimplantation Genetics Diagnosis (PGD) Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market Composition and Scenario
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Global Preimplantation Genetics Diagnosis (PGD) Market by Test Type

• 3.1 Global Aneuploidy Market by Region
• 3.2 Global Chromosomal Abnormalities Market by Region
• 3.3 Global X-linked diseases Market by Region
• 3.4 Global Single Gene Disorders Market by Region
• 3.5 Global HLA Typing Market by Region
• 3.6 Global Gender selection Market by Region
• 3.7 Global Other Test Type Market by Region

Chapter 4. Global Preimplantation Genetics Diagnosis (PGD) Market by Region

• 4.1 North America Preimplantation Genetics Diagnosis (PGD) Market
  • 4.1.1 North America Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.1.1.1 North America Aneuploidy Market by Country
    • 4.1.1.2 North America Chromosomal Abnormalities Market by Country
    • 4.1.1.3 North America X-linked diseases Market by Country
    • 4.1.1.4 North America Single Gene Disorders Market by Country
    • 4.1.1.5 North America HLA Typing Market by Country
    • 4.1.1.6 North America Gender selection Market by Country
    • 4.1.1.7 North America Other Test Type Market by Country
  • 4.1.2 North America Preimplantation Genetics Diagnosis (PGD) Market by Country
    • 4.1.2.1 US Preimplantation Genetics Diagnosis (PGD) Market
      • 4.1.2.1.1 US Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.1.2.2 Canada Preimplantation Genetics Diagnosis (PGD) Market
      • 4.1.2.2.1 Canada Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.1.2.3 Mexico Preimplantation Genetics Diagnosis (PGD) Market
      • 4.1.2.3.1 Mexico Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.1.2.4 Rest of North America Preimplantation Genetics Diagnosis (PGD) Market
      • 4.1.2.4.1 Rest of North America Preimplantation Genetics Diagnosis (PGD) Market by Test Type
• 4.2 Europe Preimplantation Genetics Diagnosis (PGD) Market
  • 4.2.1 Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.2.1.1 Europe Aneuploidy Market by Country
    • 4.2.1.2 Europe Chromosomal Abnormalities Market by Country
    • 4.2.1.3 Europe X-linked diseases Market by Country
    • 4.2.1.4 Europe Single Gene Disorders Market by Country
    • 4.2.1.5 Europe HLA Typing Market by Country
    • 4.2.1.6 Europe Gender selection Market by Country
    • 4.2.1.7 Europe Other Test Type Market by Country
  • 4.2.2 Europe Preimplantation Genetics Diagnosis (PGD) Market by Country
    • 4.2.2.1 Germany Preimplantation Genetics Diagnosis (PGD) Market
      • 4.2.2.1.1 Germany Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.2.2.2 UK Preimplantation Genetics Diagnosis (PGD) Market
      • 4.2.2.2.1 UK Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.2.2.3 France Preimplantation Genetics Diagnosis (PGD) Market
      • 4.2.2.3.1 France Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.2.2.4 Russia Preimplantation Genetics Diagnosis (PGD) Market
      • 4.2.2.4.1 Russia Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.2.2.5 Spain Preimplantation Genetics Diagnosis (PGD) Market
      • 4.2.2.5.1 Spain Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.2.2.6 Italy Preimplantation Genetics Diagnosis (PGD) Market
      • 4.2.2.6.1 Italy Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.2.2.7 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market
      • 4.2.2.7.1 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type
• 4.3 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market
  • 4.3.1 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.3.1.1 Asia Pacific Aneuploidy Market by Country
    • 4.3.1.2 Asia Pacific Chromosomal Abnormalities Market by Country
    • 4.3.1.3 Asia Pacific X-linked diseases Market by Country
    • 4.3.1.4 Asia Pacific Single Gene Disorders Market by Country
    • 4.3.1.5 Asia Pacific HLA Typing Market by Country
    • 4.3.1.6 Asia Pacific Gender selection Market by Country
    • 4.3.1.7 Asia Pacific Other Test Type Market by Country
  • 4.3.2 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Country
    • 4.3.2.1 China Preimplantation Genetics Diagnosis (PGD) Market
      • 4.3.2.1.1 China Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.3.2.2 Japan Preimplantation Genetics Diagnosis (PGD) Market
      • 4.3.2.2.1 Japan Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.3.2.3 India Preimplantation Genetics Diagnosis (PGD) Market
      • 4.3.2.3.1 India Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.3.2.4 South Korea Preimplantation Genetics Diagnosis (PGD) Market
      • 4.3.2.4.1 South Korea Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.3.2.5 Singapore Preimplantation Genetics Diagnosis (PGD) Market
      • 4.3.2.5.1 Singapore Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.3.2.6 Malaysia Preimplantation Genetics Diagnosis (PGD) Market
      • 4.3.2.6.1 Malaysia Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.3.2.7 Rest of Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market
      • 4.3.2.7.1 Rest of Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Test Type
• 4.4 LAMEA Preimplantation Genetics Diagnosis (PGD) Market
  • 4.4.1 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.4.1.1 LAMEA Aneuploidy Market by Country
    • 4.4.1.2 LAMEA Chromosomal Abnormalities Market by Country
    • 4.4.1.3 LAMEA X-linked diseases Market by Country
    • 4.4.1.4 LAMEA Single Gene Disorders Market by Country
    • 4.4.1.5 LAMEA HLA Typing Market by Country
    • 4.4.1.6 LAMEA Gender selection Market by Country
    • 4.4.1.7 LAMEA Other Test Type Market by Country
  • 4.4.2 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Country
    • 4.4.2.1 Brazil Preimplantation Genetics Diagnosis (PGD) Market
      • 4.4.2.1.1 Brazil Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.4.2.2 Argentina Preimplantation Genetics Diagnosis (PGD) Market
      • 4.4.2.2.1 Argentina Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.4.2.3 UAE Preimplantation Genetics Diagnosis (PGD) Market
      • 4.4.2.3.1 UAE Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.4.2.4 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market
      • 4.4.2.4.1 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.4.2.5 South Africa Preimplantation Genetics Diagnosis (PGD) Market
      • 4.4.2.5.1 South Africa Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.4.2.6 Nigeria Preimplantation Genetics Diagnosis (PGD) Market
      • 4.4.2.6.1 Nigeria Preimplantation Genetics Diagnosis (PGD) Market by Test Type
    • 4.4.2.7 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market
      • 4.4.2.7.1 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type

Chapter 5. Company Profiles

• 5.1 Illumina, Inc.
  • 5.1.1 Company Overview
  • 5.1.2 Financial Analysis
  • 5.1.3 Regional Analysis
  • 5.1.4 Research & Development Expense
• 5.2 Invitae Corporation
  • 5.2.1 Company Overview
  • 5.2.2 Financial Analysis
  • 5.2.3 Regional Analysis
  • 5.2.4 Research & Development Expenses
• 5.3 Natera Inc.
  • 5.3.1 Company Overview
  • 5.3.2 Financial Analysis
  • 5.3.3 Regional Analysis
  • 5.3.4 Research & Development Expenses
• 5.4 Agilent Technologies, Inc.
  • 5.4.1 Company Overview
  • 5.4.2 Financial Analysis
  • 5.4.3 Segmental and Regional Analysis
  • 5.4.4 Research & Development Expense
  • 5.4.5 Recent Strategies and Developments:
    • 5.4.5.1 Approvals and Trials:
• 5.5 PerkinElmer, Inc.
  • 5.5.1 Company Overview
  • 5.5.2 Financial Analysis
  • 5.5.3 Segmental and Regional Analysis
  • 5.5.4 Research & Development Expense
  • 5.5.5 Recent Strategies and Developments:
    • 5.5.5.1 Product Launches and Product Expansions:
• 5.6 Quest Diagnostics Incorporated
  • 5.6.1 Company Overview
  • 5.6.2 Financial Analysis
  • 5.6.3 Segmental Analysis
• 5.7 Reproductive Genetic Innovations
  • 5.7.1 Company Overview
• 5.8 PacGenomics
  • 5.8.1 Company Overview
• 5.9 CeGaT GmbH
  • 5.9.1 Company Overview
• 5.10. Laboratory Corporation of America Holdings
  • 5.10.1 Company Overview
  • 5.10.2 Financial Analysis
  • 5.10.3 Segmental and Regional Analysis